News

As part of the non-binding proposal, Perrigo shareholders would receive $205 in a combination of cash and Mylan stock for each Perrigo share. In a statement, Perrigo has

Designed to evaluate the safety and efficacy of ALX-0061, the trial is also aimed at obtaining parallel descriptive information concerning the efficacy and safety of administration of sc

The complete line of Bikini Ready’s women’s weight loss solutions includes Weight Loss Catalyst and Cleanse Cleanse nutritional supplements, as well as Yummy Nutrition Shakes. In 2014, Bikini

Tenofovir alafenamide fumarate (TAF) is a nucleotide reverse transcriptase inhibitor (NRTI) and a new prodrug of tenofovir. This is the company’s second NDA submitted to the FDA for

These tablets are the generic version of US-based pharmaceutical firm Warner Chilcott’s Generess Fe tablets. The US Food and Drug Administration (FDA) has also granted final approval for

The Phase II acne vulgaris trial will be conducted at about ten sites in Australia and New Zealand with Dr Lynda Spelman as the principal investigator. The trial

The drug sponsor, MultiCorp International, has retained Compass Point to manage the product development program. Under the deal, NDA Partners will provide the drug development and regulatory expertise

The agreement allows the alliance to establish a combined oncology sales organization in key markets in advance of the potential launch of avelumab-based treatment regimens in the future.

As part of the deal, Neurotrope will pay WCT about $300,000 for the services and related third-party costs. In early second quarter of 2015, Neurotrope plans to submit